After the Therapy: From Treatment to Growth - A Conversation with Patients

After the Therapy: From Treatment to Growth - A Conversation with Patients

🎙 MIND Foundation 👥 7K 📅 September 25, 2025 ⏱ 44 min 👁 125 📄 panel discussion 🧭 2026-08-16
Available in: English (current) Français

Keywords

psychedelic therapypatient perspectivepsilocybinketamineintegration

Summary

This panel discussion, recorded at the INSIGHT 2023 conference, features three former patients sharing their experiences with psychedelic-assisted therapy. Two patients received ketamine-assisted therapy at the OVID Clinic Berlin, and one participated in the EPIsoDE study on psilocybin for treatment-resistant depression. The patients describe their motivations, expectations, and the profound personal changes they experienced. They discuss the role of the therapist, the importance of set and setting, and the challenges of integrating their experiences into daily life. The conversation highlights the potential of psychedelic therapy to facilitate emotional and cognitive shifts that traditional therapy did not achieve for them. The panel is moderated by experts who contextualize the narratives within the broader scientific and clinical landscape.

116 words

Critical Evaluation

Value of the Information & Strength of the Argument

The value of this video lies in its authentic, first-hand accounts from patients, which are often missing in scientific discourse. The patients provide detailed narratives of their therapeutic journeys, including the challenges and breakthroughs. Their stories illustrate the subjective impact of psychedelic therapy, offering insights into mechanisms such as emotional reconnection, self-discovery, and changes in perspective. The argumentation is not scientific but experiential, and the panelists acknowledge the limitations of anecdotal evidence. The discussion is well-moderated, with experts providing context and asking probing questions that deepen the exploration.

Scientific Rigor, Source Quality, Title Accuracy

The video is a panel discussion, not a scientific study, so the rigor is limited to the credibility of the speakers and the context. The patients’ accounts are subjective and not generalizable. The moderators include professionals from the field, lending some authority. The title accurately reflects the content. No external sources are cited in the video itself, but the description links to the INSIGHT 2023 replays, which may contain more scientific content. The adequacy between title and content is high.

183 words

Title / Content Match

The title accurately reflects the content: a conversation with patients about their experiences after psychedelic therapy.

Quality & Reliability

7/10

The video is a panel discussion with patients sharing personal experiences, moderated by experts. It provides qualitative insights but lacks rigorous scientific methodology. The information is anecdotal and not peer-reviewed, but the context is credible (INSIGHT conference, MIND Foundation).

Key Moments

Cited Sources

Concurring Sources

Contribution & Novelties

This video provides a rare, patient-centered perspective on psychedelic therapy, highlighting the subjective experiences and long-term integration challenges. It complements scientific literature by offering qualitative insights that are often absent in clinical trials.

Pour aller plus loin :

  • Psilocybin for treatment-resistant depression (EPIsoDE study) — Relevant to the psilocybin study mentioned.
  • Ketamine for depression: a review — Provides scientific context for ketamine therapy.
  • Psychedelic-assisted therapy: a review — Overview of the field.

72 words

Radar Profile

The radar profile shows moderate scores across all dimensions, with slightly higher quality of information and lower technical level, reflecting the patient-focused nature of the discussion.

Reliability 6/10

💬 No comments were provided for analysis.